Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1600 1642 1648 1671 1675
This examiner grants 64% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17603789 | PHAGE TEST KIT | Final Rejection | DSM IP Assets B.V. |
| 18344952 | METHODS FOR DETERMINING SARS-COV-2 ANTIGEN AND ANTI-SARS-COV-2 ANTIBODY IN A SAMPLE | Final Rejection | Abbott Laboratories |
| 18560515 | Coronavirus Constructs and Vaccines | Non-Final OA | The Regents of the University of California |
| 17817382 | HPV VACCINE | Final Rejection | Merck Sharp & Dohme LLC |
| 17862240 | Methods for Viral Particle Characterization Using Two-Dimensional Liquid Chromatography-Mass Spectrometry | Final Rejection | Regeneron Pharmaceuticals, Inc. |
| 17800687 | Multilamellar RNA Nanoparticles and Methods of Sensitizing Tumors to Treatment with Immune Checkpoint Inhibitors | Non-Final OA | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED |
| 18283435 | METHOD TO ASSESS POTENCY OF VIRAL VECTOR PARTICLES | Non-Final OA | Juno Therapeutics, Inc. |
| 18021719 | RAPID AND LOW-COST NUCLEIC ACID DETECTION USING TRANSLATION-BASED SEQUENCE VERIFICATION ASSAYS | Final Rejection | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY |
| 18689656 | Universal Influenza Vaccine and Methods of Use | Non-Final OA | The Trustees of the University of Pennsylvania |
| 18415814 | METHOD OF DETECTING SARS-COV IN A SAMPLE | Non-Final OA | Imam Abdulrahman Bin Faisal University |
| 18017073 | GDF-15 FOR PREDICTING THE DISEASE SEVERITY OF A PATIENT WITH COVID-19 | Final Rejection | Roche Diagnostics Operations, Inc. |
| 18503487 | Vaccines For Human Papilloma Virus And Methods For Using The Same | Non-Final OA | Inovio Pharmaceuticals, Inc. |
| 17221032 | COMPOSITIONS AND METHODS FOR TREATING VULVAR DYSPLASIA | Final Rejection | Inovio Pharmaceuticals, Inc. |
| 18411772 | METHODS AND SYSTEMS FOR THE RAPID DETECTION OF SALMONELLA USING INFECTIOUS AGENTS | Non-Final OA | Laboratory Corporation of America Holdings |
| 17845629 | Methods and Systems for Detection of Covid Variants | Final Rejection | Laboratory Corporation of America Holdings |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy